Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Maffini

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Cytometry. Part B, Clinical Cytometry|July 21, 2020
ISSUE HIGHLIGHTS - July 2020Francesco Lanza, Enrico Maffini
Clinical Hematology International|October 1, 2021
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic LeukemiaEnrico Maffini, Francesco Saraceni, Francesco Lanza
Frontiers in Pharmacology|January 26, 2023
Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and managementTommaso Mazzierli, Federica Allegretta, Enrico Maffini, et al.
Expert Review of Hematology|April 5, 2016
Treatment of CMV infection after allogeneic hematopoietic stem cell transplantationEnrico Maffini, Luisa Giaccone, Moreno Festuccia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2017
Neurologic Complications after Allogeneic Hematopoietic Stem Cell TransplantationEnrico Maffini, Moreno Festuccia, Lucia Brunello, et al.
Cancers|February 5, 2020
CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in AdultsFrancesco Lanza, Enrico Maffini, Michela Rondoni, et al.
Frontiers in Bioscience (Landmark Edition)|May 29, 2019
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectivesMarta Coscia, Candida Vitale, Marco Cerrano, et al.
Expert Review of Hematology|August 20, 2019
An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantationEnrico Maffini, Alessandro Busca, Cristina Costa, et al.
Minerva Medica|September 21, 2020
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemiaFrancesco Lanza, Enrico Maffini, Francesco Saraceni, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and RuxolitinibKatia Paciaroni, Selenia Campagna, Nicoletta Villiva, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cytometry. Part B, Clinical Cytometry|July 21, 2020
ISSUE HIGHLIGHTS - July 2020Francesco Lanza, Enrico Maffini
Clinical Hematology International|October 1, 2021
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic LeukemiaEnrico Maffini, Francesco Saraceni, Francesco Lanza
Frontiers in Pharmacology|January 26, 2023
Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and managementTommaso Mazzierli, Federica Allegretta, Enrico Maffini, et al.
Expert Review of Hematology|April 5, 2016
Treatment of CMV infection after allogeneic hematopoietic stem cell transplantationEnrico Maffini, Luisa Giaccone, Moreno Festuccia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2017
Neurologic Complications after Allogeneic Hematopoietic Stem Cell TransplantationEnrico Maffini, Moreno Festuccia, Lucia Brunello, et al.
Cancers|February 5, 2020
CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in AdultsFrancesco Lanza, Enrico Maffini, Michela Rondoni, et al.
Frontiers in Bioscience (Landmark Edition)|May 29, 2019
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectivesMarta Coscia, Candida Vitale, Marco Cerrano, et al.
Expert Review of Hematology|August 20, 2019
An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantationEnrico Maffini, Alessandro Busca, Cristina Costa, et al.
Minerva Medica|September 21, 2020
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemiaFrancesco Lanza, Enrico Maffini, Francesco Saraceni, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and RuxolitinibKatia Paciaroni, Selenia Campagna, Nicoletta Villiva, et al.
Pageof 5